维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="STRANGE JW"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Recent insights into the pathogenesis and therapeuty of pulmonary hypertension显示文摘	Strange JW Wharton J Phillips PG	2002	Clin Sei(Lond)2002，102，：	1
2	Recent insights into the pathogenetics and therapeutics of pulmonary hypertension显示文摘	Strange JW Whaton J Phillips PG	2002	Clin Sci(lond)2002，102，4：	1
3	Recent insights into the pathogenesis and therapeutics of pulmonary hypertension显示文摘	Strange JW Wharton J Phillips PG	2002	Gin Sci2002，102，3：	1
4	Recent insights into the pathogenesis and therapeutics of pulmonary hypertension显示文摘	Strange JW Wharton J Phil ips PG		0，，：	1
5	Andprolifcrative efects of phosphediestemse type 5 inhibitionin human pulmonary artery ceils显示文摘	Wharton J Strange JW MoBer GM	2005	Am J Respir Crit care Med2005，，：	1
6	Recent insights into the patho- genesis and therapeutics of pulmormry hypertension 显示文摘	Strange JW Wharton J Phillips PG	2002	Clin Sci2002，102，：	1
7	Phosphoeliesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension显示文摘	Sebkhi A Strang JW Phillips SC	2003	Circulation2003，107，25：	1
8	Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study显示文摘	WILKINS MR PAUL GA STRANGE JW	2005	Am J Respir Crit Care Med2005，171，11：	1
9	Antiproliferativeeffects of phosphodiesterase type 5 inhibition in human pul-monary artery cells 显示文摘	Wharton J Strange JW M0ller GM	2005	Am J Respir Crit Care Med2005，172，1：	1
10	Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study显示文摘	Wilkins MR Paul GA Strange JW	2005	Am J Rcspir Crit Care Med2005，171，11：	1
11	ST elevation myocardial infarction and multi-vessel coronary artery disease:complete or incomplete revascularization显示文摘	Vizzi V Johnson TW Strange JW	2014	Cor et Vasa2014，56，4：	1
12	Recent insights intothe pathogenesis and therapeutics of pulmonary hypertension显示文摘	Strange JW Wharton J Phillips PG	2002	Ciin Sci2002，102，9：	1
13	Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells 显示文摘	Wharton J Strange JW Moller GM	2005	Am J Respir C''rit Care Med2005，172，：	1
14	Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study显示文摘	Wilkins MR Paul GA Strange JW	2005	Am J Respir Crit Care Med2005，171，11：	1
15	Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells显示文摘	Wharton J Strange JW Moller GM	2005	Am J Respir Crit Care Med2005，172，1：	1
16	Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study显示文摘	WILKINS MR PAUL GA STRANGE JW	2005	Am J Respir Crit Care Med2005，171，11：	1
17	Phosphodiesterase type 5 as a target for the treatment of hypoxia - induced pulmonary hypertension 显示文摘	Sebkhi A Strange JW Phillips SC	2003	Circulation2003，107，：	1
18	Sildenafil versus endo- thelin receptor antagonist for pulmonary hypertension (SER- APH) study 显示文摘	Wilkins MR Paul GA Strange JW	2005	Am J Respir Crit Care Med2005，171，11：	1
19	Antiproliferative effectsof phosphodiesterase type 5 inhibition in human pulmonary arterycells 显示文摘	Wharton J Strange JW Moller GM	2005	Am J Respir Crit Care Med2005，172，1：	1
20	Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study 显示文摘	Wilkinsm Paul GA Strange JW	2005	Am J Respir Crit Care Med2005，171，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示